Association of smoking but not HLA-DRB1*15:01,APOE or body mass index with brain atrophy in early multiple sclerosis

Abstract

Background:

The course of multiple sclerosis (MS) shows substantial inter-individual variability. The underlying determinants of disease severity likely involve genetic and environmental factors.

Objective:

The aim of this study was to assess the impact of APOE and HLA polymorphisms as well as smoking and body mass index (BMI) in the very early MS course.

Methods:

Untreated patients (n = 263) with a recent diagnosis of relapsing-remitting (RR) MS or clinically isolated syndrome underwent standardized magnetic resonance imaging (MRI). Genotyping was performed for single-nucleotide polymorphisms (SNPs) rs3135388 tagging the HLA-DRB1*15:01 haplotype and rs7412 (Ɛ2) and rs429358 (Ɛ4) in APOE. Linear regression analyses were applied based on the three SNPs, smoking and BMI as exposures and MRI surrogate markers for disease severity as outcomes.

Results:

Current smoking was associated with reduced gray matter fraction, lower brain parenchymal fraction and increased cerebrospinal fluid fraction in comparison to non-smoking, whereas no effect was observed on white matter fraction. BMI and the SNPs in HLA and APOE were not associated with structural MRI parameters.

Conclusions:

Smoking may have an unfavorable effect on the gray matter fraction as a potential measure of MS severity already in early MS. These findings may impact patients’ counseling upon initial diagnosis of MS.

Keywords

Neurodegeneration genetics MRI brain atrophy SNP gray matter risk factor smoking

Get full access to this article

View all access options for this article.

References

Beecham

Patsopoulos

Xifara

et al ; International Multiple Sclerosis Genetics Consortium (IMSGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353–1360.

Lill

Schjeide

Graetz

et al ; International Multiple Sclerosis Genetics Consortium (IMSGC). MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013; 136: 1778–1782.

Lill

Luessi

Alcina

et al . Genome-wide significant association with seven novel multiple sclerosis risk loci. J Med Genet 2015; 52: 848–855.

Lill

Schjeide

Graetz

et al . Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk. J Med Genet 2013; 50: 140–143.

Belbasis

Bellou

Evangelou

et al . Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and meta-analyses. Lancet Neurol 2015; 14: 263–273.

Bjartmar

Kidd

Mork

et al . Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 893–901.

Fisher

Lee

Nakamura

et al . Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 2008; 64: 255–265.

Zivadinov

Weinstock-Guttman

Hashmi

et al . Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 2009; 73: 504–510.

Hedstrom

Olsson

Alfredsson

Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler 2016; 22: 878–883.

10.

Ramanujam

Hedstrom

Manouchehrinia

et al . Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 2015; 72: 1117–1123.

11.

Healy

Ali

Guttmann

et al . Smoking and disease progression in multiple sclerosis. Arch Neurol 2009; 66: 858–864.

12.

Okuda

Srinivasan

Oksenberg

et al . Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009; 132: 250–259.

13.

Gourraud

Sdika

Khankhanian

et al . A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain 2013; 136: 1012–1024.

14.

Isobe

Keshavan

Gourraud

et al . Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis. JAMA Neurol 2016; 73: 795–802.

15.

De Stefano

Bartolozzi

Nacmias

et al . Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. Arch Neurol 2004; 61: 536–540.

16.

Shi

Zhao

Vollmer

et al . APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008; 70: 185–190.

17.

Horakova

Kyr

Havrdova

et al . Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: A 15-year disease history model based on a 4-year longitudinal study. Folia Biol 2010; 56: 242–251.

18.

Ghaffar

Lobaugh

Szilagyi

et al . Imaging genetics in multiple sclerosis: A volumetric and diffusion tensor MRI study of APOE ε4. Neuroimage 2011; 58: 724–731.

19.

Khan

Giampietro

Ginesteta

et al . No differences in hippocampal volume between carriers and non-carriers of the ApoE ε4 and ε2 alleles in young healthy adolescents. J Alzheimers Dis 2014; 40: 37–43.

20.

Schrewe

Lill

Liu

et al . Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS. J Neuroinflamm 2015; 12: 234.

21.

Polman

Reingold

Edan

et al . Diagnostic criteria for multiple sclerosis: 2005 Revisions to the “McDonald Criteria.” Ann Neurol 2005; 58: 840–846.

22.

Polman

Reingold

Banwell

et al . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292–302.

23.

Duriez

Crivello

Mazoyer

Sex-related and tissue-specific effects of tobacco smoking on brain atrophy: Assessment in a large longitudinal cohort of healthy elderly. Front Aging Neurosci 2014; 6: 299.

24.

Enzinger

Fazekas

Matthews

et al . Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects. Neurology 2005; 64: 1704–1711.

25.

Stoeckel

Chai

Zhang

et al . Lower gray matter density and functional connectivity in the anterior insula in smokers compared with never smokers. Addict Biol 2016; 21: 972–981.

26.

Yuan

Cai

et al . Reduced frontal cortical thickness and increased caudate volume within fronto-striatal circuits in young adult smokers. Drug Alcohol Depend 2015; 151: 211–219.

27.

Zhang

Salmeron

Ross

et al . Factors underlying prefrontal and insula structural alterations in smokers. Neuroimage 2011; 54: 42–48.

28.

Gallinat

Meisenzahl

Jacobsen

et al . Smoking and structural brain deficits: A volumetric MR investigation. Eur J Neurosci 2006; 24: 1744–1750.

29.

Karama

Ducharme

Corley

et al . Cigarette smoking and thinning of the brain’s cortex. Mol Psychiatry 2015; 20: 778–785.

30.

Fritz

Wittfeld

Schmidt

et al . Current smoking and reduced gray matter volume-a voxel-based morphometry study. Neuropsychopharmacology 2014; 39: 2594–2600.

31.

Zhao

Regional grey and white matter changes in heavy male smokers. PLoS ONE 2011; 6: e27440.

32.

Durazzo

Meyerhoff

Nixon

SJ.

A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers. Drug Alcohol Depend 2012; 122: 105–111.

33.

Sutherland

Riedel

Flannery

et al . Chronic cigarette smoking is linked with structural alterations in brain regions showing acute nicotinic drug-induced functional modulations. Behav Brain Funct 2016; 12: 16.

34.

Heilert

Kaul

Smoking behaviour in Germany: Evidence from the SOEP. Berlin: DIW Berlin, 2017.

35.

Kappus

Weinstock-Guttman

Hagemeier

et al . Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016; 87: 181–187.

36.

Muhlau

Andlauer

Hemmer

HLA genetic risk burden in multiple sclerosis. JAMA Neurol 2016; 73: 1500–1501.

37.

Schreiber

Vogel

Schwimmer

et al . Impact of lifestyle dimensions on brain pathology and cognition. Neurobiol Aging 2016; 40: 164–172.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB